Does pretreatment of bone marrow mesenchymal stem cells with 5-azacytidine or double intravenous infusion improve their therapeutic potential for dilated cardiomyopathy?

Medical science monitor basic research

Volumn 19, Issue , 2013, Pages 20-31

  Yang, Sirui ^a   Piao, Jinhua ^b   Jin, Lianhua ^b   Zhou, Yan ^b  

^a THE FIRST HOSPITAL OF JILIN UNIVERSITY   (China)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AZACITIDINE; BRAIN NATRIURETIC PEPTIDE; BROXURIDINE; COLLAGEN; MESSENGER RNA; TROPONIN T; VASCULOTROPIN A;

ANIMAL; ARTICLE; BLOOD; BODY WEIGHT; BONE MARROW CELL; CELL TRANSDIFFERENTIATION; CONGESTIVE CARDIOMYOPATHY; CYTOLOGY; DRUG EFFECT; FEMALE; FIBROSIS; GENE EXPRESSION REGULATION; GENETICS; HEART FUNCTION TEST; HEART MUSCLE; INTRAVENOUS DRUG ADMINISTRATION; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMA CELL; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; RAT; SURVIVAL; WISTAR RAT;

ANIMALS; AZACITIDINE; BODY WEIGHT; BONE MARROW CELLS; BROMODEOXYURIDINE; CARDIOMYOPATHY, DILATED; CELL TRANSDIFFERENTIATION; COLLAGEN; FEMALE; FIBROSIS; GENE EXPRESSION REGULATION; HEART FUNCTION TESTS; INFUSIONS, INTRAVENOUS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MYOCARDIUM; NATRIURETIC PEPTIDE, BRAIN; RATS; RATS, WISTAR; RNA, MESSENGER; SURVIVAL ANALYSIS; TROPONIN T; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84884791491     PISSN: None     EISSN: 23254416     Source Type: None    
DOI: 10.12659/MSMBR.883737     Document Type: Article

References (0)